PE anti-human CD158i (KIR2DS4) Antibody, CD158i, S22012A,BioLegend,335107

Based on in-house testing on different KIR-expressing transfectants, clone S22012A does not interact with other KIR protein family members.

Host

Mouse

Reactivity

Human

Application

FC - Quality tested

Platform ID

BAB886987359

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePE anti-human CD158i (KIR2DS4) Antibody, CD158i, S22012A
Cat. No.335107
HostMouse
RRIDAB_3716929 (BioLegend Cat. No. 335107)AB_3716929 (BioLegend Cat. No. 335108)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationFC - Quality tested
ClonalityMonoclonal
Clone NumberS22012A
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysisonline tool.)
TargetCD158i
ImmunogenKIR2DS4-transfected cells
PurityThe antibody was purified by affinity chromatography and conjugated with PE under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
StorageThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD158 molecules, also known as KIRs (killer cell immunoglobulin-like receptors), are a family of transmembrane proteins that are expressed on specific subsets of NK and T cells. KIRs are characterized as having either two (KIR2D) or three (KIR3D) Ig-like extracellular domains. Some KIRs with long cytoplasmic domains contain ITIMs and possess inhibitory functions, while others with short cytoplasmic region lack ITIMs and have activating functions. Fifteen polymorphic KIR genes have been identified in humans, contributing to the extensive diversity of KIR phenotypes observed in individuals.CD158i is an activating receptor with two Ig-like domains and a short cytoplasmic region. KIR2DS4 is reported to bind to certain HLA-C molecules and HLA-A*11.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.